IL9 and melanoma: Additional differences could be due to discrepancies in the tumor microenvironment between melanoma and NSCLC or the analysis of IL-9- versus Th9-dependent effects, as many studies used Th9 cell transfer-models rather than IL-9 single cytokine targeting to determine the functional relevance of IL-9.